GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » Operating Cash Flow per Share

Syngene International (NSE:SYNGENE) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Operating Cash Flow per Share?

Syngene International's operating cash flow per share for the three months ended in Mar. 2024 was ₹0.00. Syngene International's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Syngene International was 27.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 14.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 8.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Syngene International's Operating Cash Flow per Share or its related term are showing as below:

NSE:SYNGENE' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -49.3   Med: 14.9   Max: 188.3
Current: 14

During the past 13 years, Syngene International's highest 3-Year average Operating Cash Flow per Share Growth Rate was 188.30% per year. The lowest was -49.30% per year. And the median was 14.90% per year.

NSE:SYNGENE's 3-Year OCF Growth Rate is ranked better than
59.84% of 1235 companies
in the Biotechnology industry
Industry Median: 3.6 vs NSE:SYNGENE: 14.00

Syngene International Operating Cash Flow per Share Historical Data

The historical data trend for Syngene International's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Operating Cash Flow per Share Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.01 17.50 14.41 20.41 25.93

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Syngene International's Operating Cash Flow per Share

For the Biotechnology subindustry, Syngene International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Syngene International's Price-to-Operating-Cash-Flow falls into.



Syngene International Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Syngene International's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )=Cash Flow from Operations (A: Mar. 2024 )/Shares Outstanding (Diluted Average) (A: Mar. 2024 )
=10421/401.891
=25.93

Syngene International's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=0/401.290
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Syngene International's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines